(Q34308993)

1 August 2017

1 reference

title

Common hereditary cancers and implications for primary care (English)

1 reference

1 August 2017

A Lucassen

2

0 references

author name string

J Emery

series ordinal

1

1 reference

1 August 2017

M Murphy

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

358

1 reference

1 August 2017

issue

9275

1 reference

1 August 2017

page(s)

56-63

1 reference

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Evaluation of molecular genetic diagnosis in the management of familial adenomatous polyposis coli: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Cancer risk in mutation carriers of DNA-mismatch-repair genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Performance of screening mammography among women with and without a first-degree relative with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Screening for ovarian cancer: a pilot randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Chemoprevention of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

BRCA1 and BRCA2 testing: weighing the demand against the benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Family history and the risk of breast cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Assessing individual risk for breast cancer: risky business

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Validation of the Gail et al. model for predicting individual breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Validation of a breast cancer risk assessment model in women with a positive family history.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

A Prospective Study of Family History and the Risk of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Randomized trial of a specialist genetic assessment service for familial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Efficacy of screening mammography. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Interpretation of Genetic Test Results for Hereditary Nonpolyposis Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Diet and cancer prevention: the Concerted Action Polyp Prevention (CAPP) Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

The prevalence of a family history of cancer in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

A systematic review of the literature exploring the role of primary care in genetic services

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905257-0

7 January 2021

10.1016/S0140-6736(00)05257-0

Identifiers

DOI

1 reference

1 August 2017

1 reference